Publication
Article
Optimal Cholesterol Management: Implications for Managed Care
This supplement is the third part of a 3-part series to
The American Journal of Managed Care
, and addresses use of statin therapy in treating dyslipidemia in a range of high-risk populations and in real-world settings.
Faculty
Disclosure Statement
Michael H. Davidson, MD, FACC, FACPExecutive Medical Director
Director, Preventive Cardiology Center
Department of Preventive Cardiology
Chicago, Illinois
Keith C. Ferdinand, MD, FACCClinical Professor of MedicineDivision of Cardiology
Chief Scientific Officer
Atlanta, Georgia
Kathleen M. Fox, PhD, MPHAdjunct Assistant ProfessorDepartment of Epidemiology and Preventive Medicine
Baltimore, Maryland
Sanjay K. Gandhi, PhDDirector, Health Economics and Outcomes Research
Wilmington, Delaware
James M. McKenney, PharmDProfessor Emeritus
President and Chief Executive Officer
Richmond, Virginia
Robert L. Ohsfeldt, PhDProfessorDepartment of Health Policy and Management
College Station, Texas
Thomas A. Stacy, PharmDVice President, Operations
Kennesaw, Georgia
It is the policy of
The American Journal of Managed Care
to have all faculty who participate in programs sponsored by pharmaceutical organizations disclose any real or apparent conflicts of interest.
These participants report relationships with the following pharmaceutical companies: We would like to thank Wayne Kuznar and Thomas May for editorial assistance in the development of two of these articles (as noted in footnotes).
The American Journal of Managed Care
Signed disclosures are on file at the office of , Princeton, New Jersey.
Michael H. Davidson, MD, FACC, FACPConsultant to:Abbott LaboratoriesAstraZeneca Pharmaceuticals
Merck/Schering-Plough
Pfizer Inc
Roche Pharmaceuticals, Inc
Sumitomo Pharmaceuticals
Speaker's bureau for:Abbott LaboratoriesAstraZeneca Pharmaceuticals
Merck & Co, Inc
Pfizer Inc
Sankyo Pharma
Grant support from: Abbott Laboratories
Merck & Co, Inc
Novartis
Reliant Pharmaceuticals, Inc
Sankyo Pharma
Consultant to:AstraZenecaNitromed
Grant support from:AstraZenecaHonoraria from:AstraZeneca
Nitromed
Pfizer Inc
Kathleen M. Fox, PhD, MPHConsultant to:AstraZeneca Pharmaceuticals LP
Employee of:AstraZeneca Pharmaceuticals LP
James M. McKenney, PharmDConsultant to:AstraZeneca Pharmaceuticals LPKOS
Pfizer Inc
Honoraria from:AstraZeneca Pharmaceuticals LPKOS
Pfizer Inc
Grant support from:AstraZeneca Pharmaceuticals LPGlaxoSmithKline
Merck
RocheSchering-Plough
Grant support from:Amgen
Pfizer Inc
Thomas A. Stacy, PharmDEmployee of:Total Therapeutic Management, IncGrant support from:AstraZeneca Pharmaceuticals LP